GLUT4-overexpressing engineered muscle constructs as a therapeutic platform to normalize glycemia in diabetic mice

Author:

Beckerman Margarita12ORCID,Harel Chava23,Michael Inbal1,Klip Amira4ORCID,Bilan Philip J.4ORCID,Gallagher Emily J.5ORCID,LeRoith Derek5,Lewis Eli C.6,Karnieli Eddy23,Levenberg Shulamit12ORCID

Affiliation:

1. Faculty of Biomedical Engineering, Technion—Israel Institute of Technology, Haifa, Israel.

2. Rina and Avner Schneur Center of Diabetes Research, Technion—Israel Institute of Technology, Haifa, Israel.

3. Rappaport Faculty of Medicine, Technion—Israel Institute of Technology, Haifa, Israel.

4. Program in Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.

5. Division of Endocrinology, Diabetes and Bone Diseases, Samuel Bronfman Department of Medicine, Ichan School of Medicine at Mount Sinai, New York, NY 10029, USA.

6. Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Abstract

GLUT4-overexpressing engineered muscle constructs improve mice diabetic state and show a potential as a therapeutic tool.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3